Statistics for Kuros Biosciences AG (id:13176 KURN)
Valuation metrics
Market cap
755.22M
Enterprise value
425.51M
Trailing P/E (ttm)
-53.16
Forward P/E
PEG ratio
4.57
Price/Sales (ttm)
14.37
Price/Book (mrq)
7.05
Enterprise Value/Revenue
8.10
Enterprise Value/EBITDA
-139.51
Overview
Shares outstanding
37.57M
Float
14.15M
Shares short
% Held by insiders
3.00%
% Held by institutions
3.00%
Average volume (10 days)
152.06K
Average volume (90 days)
Price summary
52-Week low
3.06
52-Week high
32.00
52-Week change
84.36%
Beta
3.00
50-Day moving average
23.65
200-Day moving average
14.55
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
October 8, 2020
Ex-dividend date
Last split factor
2:1
Last split date
June 23, 2016
Financials
Fiscal yearFiscal year ends
December 31, 2023
Most recent quarter (mrq)
December 31, 2023
Profitability
Profit margin
-16.91%
Operating margin
-1.75%
Operational effectiveness
Return on assets
-3.77%
Return on equity
-14.32%
Income statement
Revenue (ttm)
1.81
Revenue per share (ttm)
1.81
Quarterly revenue growth (yoy)
Gross profit (ttm)
23.94M
EBITDA
-3,050,000.00
Net income to common (ttm)
-8,886,000.00
Diluted EPS (ttm)
3.00
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
14.28M
Total cash per share (mrq)
3.00
Total debt (mrq)
1.96M
Total Debt/Equity (mrq)
3.26
Current ratio (mrq)
273.30%
Book value per share (mrq)
2.85
Cash flow
Cash flow statement
-2,415,000.00
Levered free cash flow (LFCF)
-6,043,375.00